
Breast
Yale Cancer Center
Treatment Options in HR+ mBC: 2L and Beyond
FEATURING
Mariya Rozenblit
- 125 views
- March 7, 2023
ecancer
SABCS 2022 Phase 3 DESTINY-Breast02 Study: T-DXd Efficacy in Patients With HER2+ Unresectable/mBC Previously Treated With T-DM1
FEATURING
Ian Krop
- 51 views
- January 10, 2023
Yale Cancer Center
Primary Care Perspectives on Breast Cancer: Case-Based Panel Discussion
- 179 views
- October 21, 2022
Yale Cancer Center
Smilow Waterford Survivorship Clinic
FEATURING
Carrie Fijal
- 4 views
- August 19, 2022
Yale Cancer Center
Sexuality, Intimacy, and Menopause for Breast Cancer Survivors
FEATURING
Johanna D'Addario,
Mary Jane Minkin
- 12 views
- August 19, 2022
Yale Cancer Center
Yale Cancer Center Updates in Breast Cancer Surgery
FEATURING
Elizabeth Berger
- 7 views
- August 18, 2022
Yale Cancer Center
Yale Cancer Center on Understanding Breast Cancer
FEATURING
Jane Kanowitz
- 76 views
- August 18, 2022
- 1
Yale Cancer Center
Radiation Therapy Advances in Breast Cancer Care
FEATURING
Christin Knowlton
- 307 views
- August 18, 2022
- 2
Yale Cancer Center
Updates in Breast Cancer Surgery
FEATURING
Rachel Greenup
- 24 views
- August 4, 2022
Yale Cancer Center
An Update on Breast Medical Oncology
FEATURING
Maryam Lustberg
- 52 views
- August 4, 2022
- 1
Yale Cancer Center
Yale Cancer Center Updates on Advanced HER2+ BC: Efficacy Overview of ADCs and TKI
FEATURING
Anca Bulgaru
- 37 views
- January 7, 2021
Yale Cancer Center
HER2- Stage II/III BC I-SPY 2 Trial Results: Is There Any Activity With PARPi + IO Concurrent With Weekly Paclitaxel?
FEATURING
Lajos Pusztai
- 404 views
- September 28, 2020
- 2